Clinical Trial Update: Desloratadine to Prevent Taxane-induced Peripheral Neuropathy in Patients With Breast Cancer [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial is evaluating desloratadine to prevent taxane-induced peripheral neuropathy in patients with breast cancer, currently not yet recruitin…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Peripheral Neuropathy

Drugs mentioned

• Desloratadine (desloratadine)

Snippet

Sponsor: Montefiore Medical Center | Conditions: Breast Cancer, Peripheral Neuropathy | Phase 2 | Status: NOT_YET_RECRUITING